Purdue Pharma is testing Oxy on children in an effort to get approval for ages 6 and up.” Oh, when businesses lose their way, and forget about their mission (to be of benefit, the Hippocratic Oath) in pursuit of ever-greater riches.
OxyContin maker wants FDA backing to label addictive drug for 6-year-olds:
“The family-owned pharmaceutical company earned an estimated $2.8 billion in revenue last year from sales of the powerful opioid, part of the same drug family as morphine and heroin…The Purdue trial involves 154 children ages 6 to 16 and is slated for completion in August of next year, according to a filing submitted to the FDA. The document says that the study is currently recruiting participants.”
“There’s good medical evidence that suggests a brain that’s not fully mature is at greater risk at developing the disease of addiction,” said Andrew Kolodny, president of Physicians for Responsible Opioid Prescribing and the head of psychiatry at Maimonides Medical Center in New York City. The pediatric community underestimates those risks, he said, because they have given too much credence to drugmakers, who have systematically downplayed the dangers.
“Much of that misinformation (came from a) campaign funded by Purdue.” …Click here to read the rest at the Daily.